FDA grants AP status for Leflunomide ANDA077083 by Barr
The FDA has granted Abbreviated Approval (AP) status for Barr's ANDA077083 for Leflunomide.
Therapeutic Area
Therapeutic area intelligence for DMARD with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.